The biotech company Synlico has won a Golden Ticket from Lambda, which grants them six months of free access to an NVIDIA GH200 GPU. This prize is meant to help Synlico crack the code on diseases like cancer by understanding the true cause-and-effect relationships behind gene interactions. Synlico uses AI combined with causal discovery to navigate these pathways and steer drug development in the right direction. Their goal is to develop innovative therapies for oncology and other diseases, leveraging advanced AI technologies. With this prize, Synlico aims to accelerate their research and reduce computational bottlenecks, using the GPU instance to conduct testing faster and more cost-effectively. The company plans to release a large-scale single cell transcriptomics database with 57 million cells and 12,000 patient samples, which will be expanded in the future.